Skip to main content
Premium Trial:

Request an Annual Quote

Richard Schumacher, William Wilson, Kevin Quinlan, Carol Reed, Ansbert Gdicke, Carl Weissman, Edward Cannon, Bard Geesaman


Richard Schumacher was terminated as chairman and chief executive officer of Boston Biomedica of West Bridgewater, Mass., the company said in a release, citing personal financial reasons. Schumacher, who founded the company in 1986, will remain on the board of directors, the company said.

William Wilson

, a director, was named chairman, while Kevin Quinlan, president and COO, will continue to manage operations. The board will create a committee to seek a replacement for Schumacher and to oversee the transition. The company provides life sciences services including specimen preparation for genomics/proteomics testing.

Carol Reed was named vice president, medical affairs, for Genaissance Pharmaceuticals of New Haven, Conn. Reed previously was executive director, medical affairs. Previously, she was associate medical director in pulmonary medical research for Bayer.

Ansbert Gädicke, general partner of MPM Capital, was named chairman of the new Elixir Pharmaceuticals upon the completion of the Cambridge, Mass.-based company’s merger with Centagenetix last week. Carl Weissman, also of MPM, joined the board. Edward Cannon will head serve as president and chief executive officer. Bard Geesaman, former VP of informatics for Centagenetix, was named vice president, medical.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.